113 related articles for article (PubMed ID: 15039909)
1. Dactinomycin-induced veno-occlusive disease in rats. The hepatoprotective action of amifostine. Evaluation in a light and electron microscope.
Borowska H; Arciszewska E; Czauderna P; Sawicki B
Folia Morphol (Warsz); 2004 Feb; 63(1):91-3. PubMed ID: 15039909
[TBL] [Abstract][Full Text] [Related]
2. Experimental model of hepatic venoocclusive disease (VOD) caused by dactinomycin--preliminary report about hepatoprotective effect of amifostine.
Czauderna P; Chyczewski L; Lech K; Langner G; Bednarczuk G; Borowska H; Arciszewska E
Med Sci Monit; 2000; 6(3):446-53. PubMed ID: 11208352
[TBL] [Abstract][Full Text] [Related]
3. Reliable experimental model of hepatic veno-occlusive disease caused by monocrotaline.
Chen MY; Cai JT; Du Q; Wang LJ; Chen JM; Shao LM
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):395-400. PubMed ID: 18693175
[TBL] [Abstract][Full Text] [Related]
4. Effect of ligustrazine on mice model of hepatic veno-occlusive disease induced by Gynura segetum.
Chen Z; Huo JR; Yang L; Zhu HY
J Gastroenterol Hepatol; 2011 Jun; 26(6):1016-21. PubMed ID: 21251065
[TBL] [Abstract][Full Text] [Related]
5. Tissue-protective effects of fullerenol C60(OH)24 and amifostine in irradiated rats.
Trajković S; Dobrić S; Jaćević V; Dragojević-Simić V; Milovanović Z; Dordević A
Colloids Surf B Biointerfaces; 2007 Jul; 58(1):39-43. PubMed ID: 17317115
[TBL] [Abstract][Full Text] [Related]
6. Veno-occlusive disease in a child with rhabdomyosarcoma after conventional chemotherapy: report of a case and review of the literature.
Cecen E; Uysal KM; Ozguven A; Gunes D; Irken G; Olgun N
Pediatr Hematol Oncol; 2007 Dec; 24(8):615-21. PubMed ID: 18092252
[TBL] [Abstract][Full Text] [Related]
7. Efficiency of amifostine as a protection against doxorubicin toxicity in rats during a 12-day treatment.
Nazeyrollas P; Frances C; Prevost A; Costa B; Lorenzato M; Kantelip JP; Elaerts J; Millart H
Anticancer Res; 2003; 23(1A):405-9. PubMed ID: 12680240
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of hepatic veno-occlusive disease induced by Sedum aizoon].
Wu GL; Yu GY; Chen J
Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2402-4. PubMed ID: 19157138
[TBL] [Abstract][Full Text] [Related]
9. [Veno-occlusive disease of the liver].
Rybicka M; Krysiak R; Okopień B
Wiad Lek; 2009; 62(1):42-51. PubMed ID: 19817257
[TBL] [Abstract][Full Text] [Related]
10. The radioprotective effect of alpha2-macroglobulin: a morphological study of rat liver.
Mihailović M; Milosević V; Grigorov I; Poznanović G; Ivanović-Matić S; Grdović N; Bogojević D
Med Sci Monit; 2009 Jul; 15(7):BR188-93. PubMed ID: 19564818
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine ameliorates nitrosative stress on radiation-inducible damage in rat liver.
Kilciksiz S; Demirel C; Evirgen Ayhan S; Erdal N; Gurgul S; Tamer L; Ayaz L
J BUON; 2011; 16(1):154-9. PubMed ID: 21674868
[TBL] [Abstract][Full Text] [Related]
12. Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients.
Carreras E; Rosiñol L; Terol MJ; Alegre A; de Arriba F; García-Laraña J; Bello JL; García R; León A; Martínez R; Peñarrubia MJ; Poderós C; Ribas P; Ribera JM; San Miguel J; Bladé J; Lahuerta JJ;
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1448-54. PubMed ID: 18022574
[TBL] [Abstract][Full Text] [Related]
13. Effects of dexrazoxane and amifostine on evolution of Doxorubicin cardiomyopathy in vivo.
Bjelogrlic SK; Radic J; Radulovic S; Jokanovic M; Jovic V
Exp Biol Med (Maywood); 2007 Dec; 232(11):1414-24. PubMed ID: 18040065
[TBL] [Abstract][Full Text] [Related]
14. [Segmentary veno-occlusive disease of the liver secondary to insecticide inhalation].
Mari T; Barlattani A; Cecchini T; Potenza B; Hassan C
Clin Ter; 1994 Feb; 144(2):155-62. PubMed ID: 8181210
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the therapeutic effects of rice husk nanosilica combined with platelet-derived growth factor in hepatic veno-occlusive disease.
Al-Adham EK; Hassan AI; Shebl A; Hazem MM
Biochem Cell Biol; 2018 Oct; 96(5):682-694. PubMed ID: 29301090
[TBL] [Abstract][Full Text] [Related]
16. Hepatic veno-occlusive disease induced by Gymura segetum: report of two cases.
Dai HF; Gao Y; Yang M; Yu CH; Gu ZY; Chen WX
Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):406-8. PubMed ID: 16911940
[TBL] [Abstract][Full Text] [Related]
17. Azathioprine-induced hepatic veno-occlusive disease in a renal transplant recipient: histological regression following azathioprine withdrawal.
Kohli HS; Jain D; Sud K; Jha V; Gupta KL; Sakhuja V; Joshi K
Nephrol Dial Transplant; 1996 Aug; 11(8):1671-2. PubMed ID: 8856241
[No Abstract] [Full Text] [Related]
18. Role of amifostine on acute and late radiation nephrotoxicity: a histopathological study.
Kanter M; Topcu-Tarladacalisir Y; Uzal C
In Vivo; 2011; 25(1):77-85. PubMed ID: 21282738
[TBL] [Abstract][Full Text] [Related]
19. Prevention of radiation-induced central nervous system toxicity: a role for amifostine?
Nieder C; Andratschke NH; Wiedenmann N; Molls M
Anticancer Res; 2004; 24(6):3803-9. PubMed ID: 15736415
[TBL] [Abstract][Full Text] [Related]
20. [A vincristine-actinomycin combination and veno-occlusive disease of the liver in a child].
Chevallier B; Nègre V; Bidat E; Lagardère B
Gastroenterol Clin Biol; 1989 Nov; 13(11):953-4. PubMed ID: 2482217
[No Abstract] [Full Text] [Related]
[Next] [New Search]
